Effects of an intratumoral injection of human recombinant tumor necrosis factor-α on cerebrovascular permeability and leukocytic infiltration in a rat glioma model

Acta Neuropathologica

Volumn 93, Issue 1, 1996, Pages 78-86

  Wright, James L ^a   Merchant, Randall E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Glioma; Immunotherapy; Neutrophil; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN G; PEROXIDASE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BRAIN CIRCULATION; BRAIN HEMORRHAGE; BRAIN TUMOR; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOTION; DRUG EFFECT; ENZYMOLOGY; FISCHER 344 RAT; GLIOMA; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; LEUKOCYTE; METABOLISM; PATHOLOGY; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOVEMENT; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; ENDOTHELIUM, VASCULAR; GLIOMA; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, INTRALESIONAL; INJECTIONS, INTRAVENTRICULAR; LEUKOCYTES; PEROXIDASE; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030636865     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00007398     Document Type: Article

References (31)

1. Andersson P-B, Perry VH, Gordon S (1992) Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the the central nervous system. J Exp Med 176: 225-259
2. 14C]sucrose. J Cereb Blood Flow Metab 6:435-440
3. Braquet P, Hosford D, Braquet M, Bourgain R, Bussolino F (1989) Role of cytokines and platelet activating factor in microvascular immune injury. J Lab Clin Med 110:668-681
4. Carmichael EA (1928) Cerebral gliomata. J Pathol 31:493-510
5. Claudio L, Martiney JA, Brosnan CF (1994) Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1β or tumor necrosis factor-α. Lab Invest 70:850-861
6. Ellison MD, Merchant RE (1991) Appearance of cytokine associated central nervous system myelin damage coincides temporarily with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats. J Neuroimmunol 33: 245-251
7. Frei K, Piani D (1993) Immune-mediated injury in bacterial meningitis. Int Rev Exp Pathol 34 B:183-192
8. Gordon CR, Merchant RE, Marmarou A, Rice CD, Marsh JT, Young HF (1990) Effects of murine recombinant IL-1 on brain edema in the rat. Acta Neurochim (Wien) [Suppl] 51:268-270
9. Hartung H-P (1993) Immune-mediated demyelination. Ann Neurol 33:563-567
10. Hartung H-P, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 40: 197-210
11. Horvath CJ, Ferro TJ, Jesmok G, Malik AB (1988) Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. Proc Natl Acad Sci USA 85:9219-9223
12. Kido G, Wright JL, Merchant RE (1991) Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model. J Neurooncol 10:95-109
13. Kiwit JCW, Schmitz K-H, Daum L, Reifenberger G, Roosen N (1991) Effects of recombinant human tumor necrosis factor on rodent gliomas and normal brain. J Neurosurg 75:597-603
14. Kobayashi T, Bakay L (1971) The extracellular space in experimental brain tumors. Acta Neurol Scand 47:307-314
15. Long DM (1970) Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg 32: 127-144
16. Lui SKM, Jakowatz JG, Pollack RB, Ceraldi C, Yamamoto R, Dett C, Lopez F, Camacho C, Carson WE, Sentovich SM, Jacques D, Granger GA (1991) Effects of intracarotid and intravenous infusion of human TNF and LT on established rat gliomas. Lymph Cytokine Res 10:189-194
17. Luthert PJ, Lantos PL (1985) A morphometric study of the microvasculature of a rat glioma. Neuropathol Appl Neurobiol 11: 461-473
18. Merrill JE (1992) Proinflammatory and anti-inflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 12:167-170
19. Orita T, Nishizaki T, Kamiryo T, Aoki H, Harada K, Okamura T (1988) The microvascular architecture of human malignant glioma. Acta Neuropathol 76:270-274
20. Quagliarello VJ, Wispelwey B, Long WJ, Scheld WM (1991) Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. J Clin Invest 87:1360-1366
21. Rice CD, Merchant RE (1992) Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat. J Neurooncol 13:43-55
22. Robbins DS, Shirazi Y, Drysdale B-E, Lieberman A, Shin HS, Shin ML (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139:2593-2597
23. Sapsford I, Buontempo J, Weller RO (1983) Basement membrane surfaces and perivascular compartments in normal human brain and glial tumors. A scanning electron microscope study. Neuropathol Appl Neurobiol 9: 181-194
24. Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 123: 339-346
25. Tada M, Sawamura Y, Sakuma S, Suzuki K, Ohta H, Aida T, Abe H (1993) Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor α for the treatment of malignant gliomas. Cancer Immunol Immunother 36:251-259
26. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1 and fatal outcome. J Exp Med 169: 333-338
27. Watts RG, Wright JL, Atkinson LL, Merchant RE (1989) Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2. Neurosurgery 25:202-208
28. Wright JL, Merchant RE (1992) Histopathological effects of intracerebral injections of human recombinant tumor necrosis factor-α in the rat. Acta Neuropathol 85:93-100
29. Wright JL, Merchant RE (1994) Blood-brain barrier changes following an intracerebral injection of human recombinant tumor necrosis factor-α in the rat. J Neurooncol 20:17-25
30. Yamasaki T, Moritake K, Paine JT, Fukuda M, Ohta F, Naitoh H (1994) Intratumoral administration of tumor necrosis factor-alpha for malignant gliomas - two case reports. Neurol Med Chir (Tokyo) 34:216-220
31. Yoshii Y, Sugiyama K (1988) Intercapillary distance in the proliferating area of human glioma. Cancer Res 48:2938-2941